Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of proposed schedule of Analyst/ Institutional Investor meeting(s) are attached Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window
We wish to inform you that as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s code for Prevention of Insider Trading, the Trading Window, shall be closed from January 01, 2023 and would be re-opened after 48 hours from the date of announcement/ declaration of Financial Results for the Quarter and Nine Months ending December 31, 2022
Diagnostic firm shares Dr Lal PathLabs, Metropolis surge on China covid concern
The Indian government on Tuesday urged all states and union territories to ramp up the whole genome sequencing of positive samples to keep track of newer variants. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Intimation Of Results Of Postal Ballot
We wish to inform you that the Shareholders of the Company have approved the following Special Resolution(s) through Postal Ballot w.e.f. December 14, 2022: 1. Appointment of Mr. Rohit Bhasin (DIN: 02478962) as an Independent Director of the Company 2. Payment of commission to Mr. Rohit Bhasin (DIN: 02478962) as an Independent Director of the Company In this regard, please find enclosed the following documents: 1. Details of the voting results in prescribed format as required under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - 1. 2. Report of the Scrutinizer on e-Voting results as Annexure - 2. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of proposed schedule of Analyst/ Institutional Investor meeting(s) attached. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Wasatch Advisors, Inc.